McKesson Corporation (MCK) Presents at Evercore 8th Annual Healthcare Conference Transcript
McKesson Corporation (MCK) Presents at Evercore 8th Annual Healthcare Conference Transcript
Here's Why McKesson (MCK) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
3 Reasons Growth Investors Will Love McKesson (MCK)
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Here's Why McKesson (MCK) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here is Why Growth Investors Should Buy McKesson (MCK) Now
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down
McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.
McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript
McKesson Corporation ( MCK ) Q2 2026 Earnings Call November 5, 2025 4:30 PM EST Company Participants Jeni Dominguez - Head of Investor Relations Brian Tyler - CEO & Director Britt Vitalone - Executive VP & CFO Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Brian Tanquilut - Jefferies LLC, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Charles Rhyee - TD Cowen, Research Division Eric Percher - Nephron Research LLC Kevin Caliendo - UBS Investment Bank, Research Division Daniel Grosslight - Citigroup Inc., Research Division Allen Lutz - BofA Securities, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division George Hill - Deutsche Bank AG, Research Division Michael Cherny - Leerink Partners LLC, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Presentation Operator Welcome to McKesson's Second Quarter Fiscal 2026 Earnings Conference Call. Please be advised that today's conference is being recorded.
